Sentences with phrase «multicenter double»

Studies showed help with pain and sleep One multicenter double - blind study, published in 2005 in the journal Arthritis & Rheumatism, found that Lyrica reduced symptoms of pain, disturbed sleep and fatigue, and that the drug was «generally well - tolerated,» with the most frequent side effects being dizziness and sleepiness.

Not exact matches

Another more recent study assessed the efficiency of collagen peptides in a randomized, double blind, controlled multicenter trial, in which 250 subjects with primary osteoarthritis of the knee were given 10g of collagen peptides daily.

[1] Lugo JP, et al. «Efficacy and tolerability of an undenatured type ll collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double - blind, placebo - controlled study.»

He points to research by a Stanford University researcher, Allan K. Mishra, who has studied PRP for years, whose in his most recent published research includes a large multicenter study [8] involving a host of well - respected orthopedic surgeons around the country who followed 230 patients in a double - blind randomized control study [the gold standard for medical research].

A total of 2,129 patients with mild dementia due to Alzheimer's disease participated in the double - blind, placebo - controlled, phase 3 multicenter trial.

These findings are similar to those of an earlier, multicenter study that found the risk of a major cardiovascular event more than doubled in patients with the genetic mutations who took clopidogrel.

The study is believed to be the first and largest, multicenter, double - blind, randomized controlled trial of its kind to investigate the use of sublingual immunotherapy against ragweed allergy.

Researchers at Mount Sinai and in the European Union conducted two multicenter, randomized, double - blind, placebo - controlled trials of subcutaneous implants containing afamelanotide.

A Randomized, Multicenter, Double Blind, Phase III Study of Nivolumab or Placebo in Subjects with Resected Lower Esophageal, or Gastroesophageal Junction Cancer

A Phase 3, Multicenter, Randomized, Double - Blind, Placebo - Controlled Study of AG - 120 in Previously - Treated Subjects with Nonresectable or Metastatic Cholangiocarcinoma with an IDH1 Mutation

A Phase III, Multicenter, Randomized, Placebo - Controlled, Double - Blind Study Of Atezolizumab (Anti − PD - L1 Antibody) As Adjuvant Therapy In Patients With Renal Cell Carcinoma At High Risk Of Developing Metastasis Following Nephrectomy

This double - blind multicenter trial enrolled 282 patients with advanced colorectal cancer for whom all available standard therapies had failed.

METHODS: This randomized, multicenter, placebo - controlled, double - blind trial of IM AN1792 225 microg plus the adjuvant QS - 21 50 microg (300 patients) and saline (72 patients) included patients aged 50 to 85 years with probable AD, Mini-Mental State Examination (MMSE) 15 to 26.

[3] Barnett, M., et al. «Treatment of rheumatoid arthritis with oral type II collagen: Results of a multicenter, double blind, placebo - controlled trial.»

Study of the ketogenic agent AC - 1202 in mild to moderate Alzheimer's disease: a randomized, double - blind, placebo - controlled, multicenter trial.

«Double - blind, multicenter trial comparing acetyl l - carnitine with placebo in the treatment of fibromyalgia patients.»

In a recent trial for ulcerative colitis, a multicenter, randomized, placebo - controlled, double - blind study found that more than 50 percent of patients achieved remission within just one month on curcumin compared to none of the patients who received the placebo.

Study of the ketogenic agent AC - 1202 in mild to moderate alzheimer's disease: A randomized, double - blind, placebo - controlled, multicenter trial.

MOVES is a multicenter, randomized, parallel - group, double - blind, controlled clinical trial that enrolled 606 patients at 42 centers in France, Germany, Poland and Spain.